FSANZ calls for comment on infant formula method
Food Standards Australia New Zealand (FSANZ) is requesting comments on an application it has received to allow a new method of producing an already-used oligosaccharide, 2′fucosyllactose (or 2ʹ-FL for simplicity).
The oligosaccharide is already added to infant formula but the new method would use a different method of production that involves a genetically modified Escherichia coli strain. The resulting 2ʹ-FL is identical to the oligosaccharide that is produced in human milk and the E. coli strain that is being used is also permitted for production of other substances. FSANZ analyses showed no safety concerns or published health issues with the substance.
2ʹ-FL produced by a strain of genetically modified bacteria is already permitted for use and another application for a different strain is currently undergoing assessment.
The submissions for the application will be closed from 6 pm (Canberra Time), 31 January 2022.
To submit a comment regarding this application, this is the page to use. To read more about the application and method, peruse this page and its links.
CCEP inspires young workers to create influential change
Coca-Cola Europacific Partners has partnered with Year13 to empower young Australians with the...
Helen Strachan appointed Chair of Australian Grape & Wine
At Australian Grape & Wine's Annual General Meeting this week, Helen Strachan was...
Boosting plant-based protein manufacturing in regional NSW
Last month, the NSW Government launched a prospectus aimed at metropolitan and international food...
